[1]
N. Vinay and D. C. David, “Evaluation and comparison of anti-cancer activity of dapagliflozin and canagliflozin in oral cancer cell line: an in vitro study”, Int J Basic Clin Pharmacol, vol. 8, no. 3, pp. 473–477, Feb. 2019.